ericm121 - PowerPoint PPT Presentation

About This Presentation
Title:

ericm121

Description:

The global software testing market size is estimated to grow from USD 42.5 billion in 2020 to USD 69.3 billion by 2027, at a CAGR of 8.5% from 2021 to 2027. The growing adoption of web-based applications for remote working in the software industry is augmenting the demand for AI-based solutions. Various companies integrate these technologies into their software testing tools to ensure software efficiency, fueling the market growth. Major industry players are investing in integrating AI technology to provide high-quality software solutions to clients and improve their market position. – PowerPoint PPT presentation

Number of Views:44
Slides: 12
Provided by: ericm121
Category: Other
Tags:

less

Transcript and Presenter's Notes

Title: ericm121


1
Market Research Report EXCLUSIVE EDITION
Global Biobanking Market Research Report
Global Industry Analysis, Forecast and Trends,
2021-2027
2
Global Biobanking Market Research Report 2020
Statsville Consulting Private Limited
Market Statsville Group (MSG) A part of
Statsville Consulting Private Limited American
Office 416, East Standsberry Street, Perkins,
Oklahoma 74059, USA EMEA 1165 Budapest 16 Diósy
Lajos u. 24., Europe Asia-Pacific Office F-178
Subhash Marg C Scheme, Ashok Nagar, Jaipur,
Rajasthan, 302001 www.marketstatsville.com
Disclaimer Any information and/or material
provided by Statsville Consulting Private
Limited, including any and all the analysis
and/or research from Market Statsville Group
(MSG), is offered to a selected group of
customers in response to orders for such
information, material, analysis, and/or research.
As a customer of Statsville Consulting, you
acknowledge that our information, material,
and/or services are for your internal use only,
and not for any external use and/or
dissemination, or general publication, and/or
disclosure to any third parties. Any and all the
information and/or material provided by
Statsville Consulting are based on primary
interviews and/or secondary research, and are,
therefore, subject to fluctuation and variance.
Statsville Consulting takes no responsibility for
any incorrect information and/or material
supplied to us by sources we rely on, and no part
of our analysis or research may be given, lent,
resold, or disclosed to any third parties,
including non-customers, without explicit or
written permission from Statsville Consulting.
Unauthorized reproduction and/or transmission of
our information, material, analysis, and/or
research in any form and by any means, including
photocopying, mechanical/electronic recording, or
otherwise, without the explicit and written
permission of Statsville Consulting, is expressly
and clearly prohibited. Any use of the
information, material, analysis, and/or research
provided by Statsville Consulting is at your sole
risk you acknowledge that the information,
material, analysis, and/or research is provided
as is and that Statsville Consulting provides
no warranty of any kind, express or implied, with
regard to the information, material, analysis,
and/or research, including but not limited to,
merchantability and fitness for any purpose
and/or use. At the end, Statsville Consulting
will be responsible for the final decision of any
action.
3
ABOUT MARKET STATSVILLE GROUP (MSG)
Market Statsville Group (MSG) partners with
companies and society to confront their essential
risks and challenges to capture the enormous
opportunities for them. MSG was initiated its
working in 2017, and since then, the brand is
moving to become a pioneer in business advisory
and market research services. Market Statsville
is the leading market research and strategy
builder with the depth and breadth of solutions
that perfectly suit your every need. MSG provides
solutions in a wide range of industry verticals
in the form of market sizing, analysis, and
incisive business insights. MSG experienced
research analysts are proficient at digging deep
and providing a variety of customizable data that
help you make decisions with clarity, confidence,
and impact. Market Statsville is your global data
intelligence partner for reliable market research
data, data gathering, and analytical services.
MSG also has an extensive network of top-flight
domestic and global research personals around the
world, enabling us to provide high-quality
worldwide research solutions that cater to a
well-established company, government
organizations, or a startup. MSG's clients have
the authority to work directly with one or more
of our researchers to gather the most useful data
knowledge and analytical plan to formulate it in
the actual practice. Market Statsville Group
believes that to succeed, companies or
individuals must blend digital and human
capabilities most efficiently. MSG diverse and
experienced global team of business consultants
and market researchers will ensure the valuable
reports for our clients through digging in-depth
market information and functional expertise to
continuously spark the changes and real-time
valuation of variation in the market/industry.
MSG works in a uniquely collaborative model
throughout the business process across the globe
to assist the client's company with the most
accurate information that they are aiming for in
the reports.
4
RESEARCH PROCESS
Our research is an optimum culmination of
secondary and primary research, with the latter
playing a major role. We also have an in-house
repository and access to a number of external
regional and global paid databases to help
address specific requirements of our clients. The
research process begins with a holistic secondary
research, followed by expert interviews. The
information gathered is then comprehensively
analyzed by our highly experienced in-house
research panel
5
Biobanking Market 2021 Industry Size, Regions,
Emerging Trends, Growth Insights, Opportunities,
and Forecast By 2027
Biobanking Market by Specimen Type (Blood
Products, Solid Tissue, Cell Lines, Nucleic Acid,
and Others), by Type of Biobank (Population-Based
and Disease-Oriented), by Ownership, by
Application, by End-User, by Region Global
Forecast To 2027
Market Overview
The Market Statsville Group (MSG) publishes the
new report on the "Biobanking Market by Specimen
Type (Solid Tissue, Cell Lines, Nucleic Acid,
Blood Products, and Others), by Type of Biobank
(Population-Based Biobanks and Disease-Oriented
Biobanks), by Ownership (National Agency,
Non-Profit Organization, Universities, and
Private Organization), by Application
(Therapeutic and Research), by End-User (Academic
Institutions and Pharma Biotech Companies), by
Region Global Share and Forecast To 2027 By
2027, the global biobanking market size is
expected to grow USD 60405.0 million from USD
42,104.3 million in 2020, at a CAGR of 6.2
during the forecast period. Biobank specimens are
used to treat a variety of chronic diseases such
as cancer, cardiovascular diseases, neurological
disorders, immunological disorders, and other
rare metabolic diseases.
6
  • These diseases cannot be treated using
    conventional therapies, as they lead to harmful
    side effects. However, the risk of these side
    effects could be reduced by integrating these
    therapies with stem cell therapy, which acts as a
    healing agent to reduce the damage caused by
    treatment doses. These combination therapies are
    especially beneficial for oncology treatment, as
    the prevalence rate of fatal diseases like cancer
    is rising.
  • Browse 211 market data Tables and 63 Figures
    spread through 234 Pages and in-depth TOC
    on "Biobanking Market Research Report
    2021-2027.
  • Get Free Sample Report https//www.marketstatsvil
    le.com/request-sample/biobanking-market
  • Global Biobanking Market Segmentation
  • The overall biobanking market has been segmented
    into specimen type, biobank type, ownership,
    application, end-user, and region.
  • By Specimen Type (Blood Products, Solid Tissue,
    Cell Lines, Nucleic Acid, and Others)
  • By Type of Biobank (Population-Based Biobanks and
    Disease-Oriented Biobanks)
  • By Ownership (National/Regional Agency,
    Non-Profit Organization, Universities, and
    Private Organization)
  • By Application (Therapeutic and Research)

7
  • By End-User (Academic Institutions and Pharma
    Biotech Companies)
  • By Region (US, Mexico, Canada, Germany, France,
    UK, Italy, Spain, China, India, South Korea,
    Japan, Southeast Asia, Australia, Saudi Arabia,
    Peru, South Africa, Qatar, UK, Nigeria, Israel,
    Brazil, Argentina)
  • The disease-oriented biobanks segment, by
    biobank type, is estimated to hold the largest
    market share during the forecast period
  • On the basis of the type of biobank, the market
    is bifurcated into population-based biobanks and
    disease-oriented biobanks. The disease-oriented
    biobanks segment was the highest contributor of
    66.6 of the global biobanking market in 2020,
    and it is expected to register a significant CAGR
    from 2021 to 2027. Disease-oriented biobanks,
    also known as clinical biobanks, collect
    biological samples from patients and aim to
    discover and validate diseases' genetic and
    non-genetic risk factors. Furthermore,
    disease-oriented biobanks are established in
    affiliation with hospitals and research
    institutes, through which they collect samples
    representing a variety of diseases and disorders,
    possibly to look for biomarkers affiliated with
    the disease.

8
Stem cells exhibit the capability of discerning
and regenerating various kinds of cells in the
human body. These cells possess the potential to
cure life-threatening diseases such as
oncological and blood-related disorders.
Furthermore, cord blood stem cells find
application in treating more than 80
blood-related ailments, such as sickle cell
disease. Buy Now at 25 discount https//www.mar
ketstatsville.com/buy-now/biobanking-market Europ
e accounts for the largest market share in
biobanking market 2020 Based on the regions, the
global biobanking market has been segmented
across North America, Asia-Pacific, Europe, South
America, and the Middle East Africa. In 2020,
The Europe biobanking market accounted for the
highest share of 39.4 and is expected to
continue its dominance throughout the forecast
period. This is attributed to the early adoption
of advanced technologies and increased awareness
of biobanking among healthcare professionals and
individuals working in the RD industry. The
European biobanking market is covered with
respect to Germany, France, the UK, Italy, Spain,
and the rest of Europe. Germany Contributes
maximum toward the European market growth, owing
to the introduction of novel therapies, such as
personalized medicines.
9
Stem cell practices are rising in European
countries and contribute to developing new
solutions for various diseases. Furthermore,
several advancements have been made in
regenerative medicines through stem cell
technology over the past decade. Therefore, it
has become one of the vital treatment methods for
diseases, such as Alzheimer's, cancer, diabetes,
and rare genetic diseases. To benefit from the
existing therapies, umbilical cord cells and
other stem cells are preserved in biobanks. This
research report includes a study on the
development and marketing strategies, along with
a study on the product portfolios and winning
strategies of the leading companies operating in
the biobanking market. It also consists of the
profiles of leading companies such as Geneticist
Inc, Firalis S.A., AMS biotechnology Ltd., Bay
Biosciences LLC, CTI Biotech, Cureline, Inc., US
Biolab Corporation, Inc., BioIVT Elevating
Science ProteoGenex, Inc., and Boca Biolistics.
These market players have focused on acquisitions
and expansion to gain a larger market share in
the biobanking market. Browse complete
report https//www.marketstatsville.com/biobankin
g-market
10
About Market Statsville Group Market Statsville
Group (MSG) is a business research and consulting
platform of Statsville Consulting Private
Limited, based in Oklahoma, USA. MSG is the
leading market research and strategy builder with
the depth and breadth of solutions that perfectly
suit your every need. MSG provides solutions in a
wide range of industry verticals in market
sizing, analysis, and intelligent business
insights. MSG has experienced research analysts
who are proficient at digging deep and providing
various customizable data that help you make
decisions with clarity, confidence, and impact.
Furthermore, Market Statsville Group already
benefited more than 1,000 companies each year for
their revenue planning. It helped them take their
disruptions/innovations early to the market by
providing them research ahead of the curve. MSG
has an entire repository of research reports on
more than 1,000 niche industries, 3,000
high-growth potentials markets, 5,000 data sets,
and more than 12,000 company profiles.
11
Thank You
Market Statsville Group (MSG)
F-178 Subhash Marg C Scheme, Ashok Nagar, Jaipur,
Rajasthan, 302001 Phone 91 702 496 8807 Mail
sales_at_marketstatsville.com
416, East Standsberry Street, Perkins, Oklahoma
74059, US Phone 1 580 250 2707 Mail
sales_at_marketstatsville.com
Write a Comment
User Comments (0)
About PowerShow.com